Anteris Technologies Global Corp.

AVR
NASDAQMedical Instruments & Supplies

-5.3%

since IPO

IPO Price

$6.00

Current Price

$5.68

Return

-5.3%

Market Cap

$552.3M

IPO Date

Dec 13, 2024

Lockup End

Jun 11, 2025

Lockup Status

Lockup expired 322days ago

Price Performance

Stock price vs IPO price over time (sample data)

Stock Price
IPO Price
Lockup End

Performance Summary

First Day
N/A
1 Month
N/A
3 Months
N/A
6 Months
N/A
1 Year
N/A
Since IPO
-5.3%

Anteris Technologies Global Corp. (AVR) — IPO Analysis

By Kian O Connor | Updated 4/29/2026

Company Overview

Anteris Technologies Global Corp. (ticker: AVR) specializes in laboratory diagnostics while maintaining strategic capabilities in surgical instrument innovation, positioning itself within the Medical Instruments & Supplies sector through enhanced precision control and specialized service delivery. The company has developed its operations around improved patient safety, creating market differentiation through specialized expertise and usage-based billing that supports sustainable growth and customer relationship development. The company completed its public offering on 2024-12-13, accessing capital markets during evolving industry dynamics within the Medical Instruments & Supplies landscape. The IPO timing reflected the company's strategic positioning and growth trajectory, with market reception emphasizing management's execution capabilities and the company's approach to laboratory diagnostics as key value creation drivers in an evolving competitive environment. Post-IPO trading performance has demonstrated mixed market reception as investors assess business model adaptation and strategic positioning within industry trends. Market assessment focuses on the company's enhanced precision control and strategic emphasis on surgical instrument innovation as indicators of long-term competitive positioning within the Medical Instruments & Supplies sector, with investors evaluating operational execution and market opportunity capture relative to industry development trends. The lockup period expires September 25, 2025, providing market insights into management and early investor confidence in strategic direction and competitive positioning. Given the company's focus on laboratory diagnostics and emphasis on improved patient safety, insider trading decisions will likely reflect assessments of execution progress, competitive dynamics, and growth opportunity realization within the evolving Medical Instruments & Supplies market landscape.

Performance Overview

Since going public at $6.00 per share on Dec 13, 2024, Anteris Technologies Global Corp. shares have declined 5.3%, disappointing investors who participated in the IPO. The stock currently trades at $5.68, giving the company a market capitalization of $552.3M.

Lockup Expiration

The lockup period for Anteris Technologies Global Corp. expired 322 days ago on Jun 11, 2025. Insiders and early investors are now free to sell their pre-IPO shares. The post-lockup trading period is often volatile as the market absorbs any additional supply from insider selling.

Industry Context

Anteris Technologies Global Corp. operates in the Medical Instruments & Supplies sector, which has seen varied IPO activity in recent years. The company is headquartered in the United States and is classified under SIC code . Understanding the competitive landscape and sector dynamics is essential for evaluating the long-term prospects of any newly public company in this space. Investors should consider broader market conditions, sector-specific trends, and company fundamentals when assessing AVR as an investment.

Trading History

Anteris Technologies Global Corp. is actively trading in the public markets with a current share price of $5.68. The company went public at $6.00 per share, representing a decline of 5.3% from the initial offering price. With a current market capitalization of $552.3M, Anteris Technologies Global Corp. continues to establish its presence as a publicly traded entity in the Medical Instruments & Supplies.

Important Disclaimer

This analysis of Anteris Technologies Global Corp. (AVR) is provided for informational purposes only and should not be construed as investment advice. All data is sourced from SEC EDGAR filings and public market feeds. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. IPOLockup.io is an independent research platform with no financial interest in any of the companies covered.

Insider Selling Activity

Estimated insider trading activity around lockup expiry period (sample data)

2
Pre-Expiry Average
Minimal
78
Expiry Day
Very High
57
Post-Expiry (30d)
High

Activity Heatmap

60 days before/after lockup expiry
Intensity Scale:
Minimal
Low
Moderate
High
Very High
Lockup Expiry

About This Data

This heatmap shows estimated insider selling activity based on typical patterns around lockup expiry periods. Actual data would be derived from SEC Form 4 filings. Higher intensity indicates more insider transactions, which may correlate with increased selling pressure and potential stock price volatility.

Related IPOs

TickerCompanyIndustryIPO DateIPO PriceCurrentReturn
MDLNMedline Inc.Medical Instruments & SuppliesDec 17, 2025$29.00$44.24+52.5%
RGNTRegentis Biomaterials Ltd.Medical Instruments & SuppliesDec 4, 2025$8.00$3.00-62.5%
CUPRCuprina Holdings (Cayman) LimitedMedical Instruments & SuppliesApr 10, 2025$4.00$0.28-92.9%
KMTSKestra Medical Technologies, Ltd.Medical Instruments & SuppliesMar 6, 2025$17.00$21.66+27.4%
NNNNAnbio BiotechnologyMedical Instruments & SuppliesFeb 19, 2025$5.00$27.81+456.2%
ONEGOneConstruction Group LimitedEngineering & ConstructionDec 31, 2024$4.00$8.31+107.8%
BYAHPark Ha Biological Technology Co., Ltd.Household & Personal ProductsDec 27, 2024N/A$1.08N/A
HITHealth In Tech, Inc.Software - ApplicationDec 23, 2024$4.00$1.49-62.8%

Related IPO Analysis

KO
By • Founder & Data Analyst